Hit enter to search or ESC to close
ERA4TB
  • The Project
  • Consortium
  • News
    • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint

Results

Menu
  • Publications
  • Deliverables

Publications

Publications related to relevant scientific background of ERA4TB

Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions

A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth

Deliverables

D4.2 Implementation of PK/PD MALDI-MS imaging to analyses infected tissue

D2.1. Implementation of HFS-TB in a BSL3 setting in Europe

D1.10 First Report on clinical and preclinical datasets standardized and integrated into the DDIM

D1.3 Instantiation of EU-based Drug Development Information Management (DDIM) system

D1.4 Initial standardized data templates for collection and reporting of clinical and preclinical data available to Consortium members

D1.8 Standardized templates for collection and reporting of clinical and preclinical data available to consortium members –Interim reportD1.6 Availability of existing preclinical and clinical TB datasets – Interim Report

D1.6 Availability of existing preclinical and clinical TB datasets – Interim Report

D3.1 First Report on implementation of selected mouse models for in vivo evaluation of drug candidates

D8.1 Project Handbook

D8.4 Project Communication Plan

Know how accelerate the development of new treatment regimens for tuberculosis, discover our project

The Project
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Newsletter
  • Events
  • Media
Result
  • Publications
  • Deliverables

© 2023 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.